3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
5
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma of Lung
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Smoking Cessation
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Phyllodes Tumor
1
Pancreatic Neoplasms
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Multiple Pulmonary Nodules
1
Lymphoma, Follicular
1
Lung Diseases
1
Locally Advanced Pancreatic Cancer
1
Liver Cirrhosis
1
Inflammatory Bowel Diseases
1
Hypertension, Portal
1
Head and Neck Neoplasms
1
Interventions
Echocardiography
14
Doxorubicin
10
Exercise
8
Electrocardiography
7
Trastuzumab
6
Cyclophosphamide
5
Carvedilol
5
Docetaxel
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Magnetic Resonance Spectroscopy
2
Ivabradine
2
High-Intensity Interval Training
2
Exercise Test
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Bisoprolol
2
Antineoplastic Agents
2
Anthracyclines
2
sulforaphane
1
schizandrin
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
mitoquinone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiotoxicity
×
Diagnostic Imaging
×
Clear all
NCT06986291
2025-05-29
CorTox
Technische Universität Dresden
Phase NA
Not yet recruiting
325 enrolled